查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138308

全球蛋白质检测量化市场-2022-2029

Global Protein Detection Quantification Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球蛋白质检测量化市场的增长受到某些因素的推动，例如创伤数量的增加。此外，在分子水平上了解慢性病和开发治疗方案的需求日益增长，也是推动市场增长的主要因素之一。

在分子水平上了解慢性病、开发治疗解决方案和鼓励这些组织为其研发项目提供资金的需求日益增长，预计将在预测期内推动市场发展。

美国国家癌症研究所 (NCI) 的公共卫生基因组学将个性化医学和基因组学推进到公共卫生癌症研究中，以减轻全球癌症负担。

政府通过资助蛋白质组学行业来鼓励研究活动。因此，蛋白质检测和量化市场预计将在未来几年显着增长。人类蛋白质组组织、国家癌症研究所 (NCI) 和基因组健康公司等组织的存在促进了资金支持蛋白质组学领域的研发和产品开发活动。

此外，为阐明生物製剂的物理和化学降解途径的机製而进行的蛋白质组学研究有望促进进展。此外，下一代蛋白质浓度估计技术的发展有望推动具有潜力的市场。

此外，通过蛋白质组学和基因组学研究开发的各种候选生物标誌物可以成为製造更安全、更有效药物的预测指标。在探索阶段，基于质谱的蛋白质组学分析可以识别与疾病进展相关的特定机制相关且受药物治疗影响的候选者。

儘管简化蛋白质估计的技术不断进步，但技术和检测的高成本预计会限制这些检测和技术在某些情况下的实用性。例如，通常用于功能蛋白质组学的质谱 (MS) 被认为对研究人员来说既昂贵又耗时。靶向 MS 需要针对每个靶标定制抗体，以进行□的免疫亲和富集。靶向 MS 还需要针对每个靶点定制抗体，以通过免疫亲和性富集□，这既昂贵又耗时。

据推测，在分子水平上了解各种慢性疾病和开发治疗方法的需求日益增加，这将支持对这些组织的研发计划的投资。此外，美国国家癌症研究所 (NCI) 公共卫生基因组学正在帮助将基因组学和个性化医学整合到公共卫生癌症研究中，以减轻全球癌症负担。

COVID-19 影响分析

COVID-19 的爆发对市场的增长产生了负面影响。中心将关闭，实验室将因 COVID-19 测试而不堪重负，从而在预测期内阻碍市场增长。

行业分析

全球蛋白质检测量化市场根据波特五力分析、供应链分析、监管分析和价格分析等各种行业因素对市场进行深入分析。

全球蛋白质检测量化市场报告提供了大约 40 多个市场数据表、45 多个图表和 180 页的结构。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按技术划分的市场细分
  • 按产品划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
  • 驱动程序
    • 越来越需要在分子水平上了解各种慢性病
    • 实验室对蛋白质定量的需求不断增加
  • 限制因素
    • 分析和技术的高成本预计会限制其使用。
  • 影响分析
  • 商机

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 产品分析
  • 售后服务分析

第 6 章按技术分类

  • 比色测量方法
  • 免疫学技术
  • 色谱法
  • 质谱仪
  • 光谱分析仪
  • 其他

第 7 章按产品分类

  • 试剂盒/试剂/耗材
  • 设备
  • 服务

第 8 章. 按应用程序

  • 药物发现和药物开发
  • 临床诊断
  • 其他

第 9 章，最终用户

  • 学术研究所
  • 生物製药公司
  • 委託研究机构
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 12 章公司简介

  • 默克公司
    • 公司简介
    • 产品组合和描述
    • 主要发展状况
    • 财务摘要
  • Danaher
  • RayBiotech, Inc.
  • Inanovate, Inc.
  • Shimadzu Corporation
  • PerkinElmer Inc
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • GE Healthcare
  • Hartalega Holdings Bhd（*List is not exhaustive）

第13章 DataM

简介目录
Product Code: DMBT2609

Market Overview

Protein detection quantification market size was valued at US$ 2.25 billion in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 9.60% during the forecast period (2022-2029).

Detection and subsequent quantification of proteins is a vital step in the understanding of post-translational modifications. It assists in understanding the functions of complex networks of peptides for use in medicine and cell biology. Increased demand for quantification of protein in laboratories that are engaged with various activities. These laboratories' activities range from drug dosing and clinical diagnostic testing to protein characterization and are likely to influence industrial growth in the years to come.

Market Dynamics

The global protein detection quantification market growth driven by certain factors such as by rising number of traumatic injuries drives the market. The market growth is also majorly driven by the increasing need to understand chronic diseases at a molecular level and develop therapeutic solutions to encourage these organizations to fund research and development programs are among the key factors driving the market growth.

Increasing need to understand chronic diseases at a molecular level and develop therapeutic solutions to encourage these organizations to fund research and development programs., is expected to drive the market during the forecast period

Public Health Genomics at the National Cancer Institute (NCI) promotes personalized medicine and genomics into public health cancer research to reduce cancer burden across the globe.

Governments are encouraging research activities by raising funds in the proteomics industry. Thus, the protein detection and quantification market are anticipated to grow significantly in the coming years. The presence of organizations such as the Human Proteome Organization, National Cancer Institute (NCI), and Genomic Health Inc. promotes funding to support R&D and product development exercises about the field of proteomics.

Furthermore, proteomic studies carried out for finding the mechanism of physical and chemical degradation pathways of biologics are anticipated to propel progress. In addition to advancements, the development of next-generation protein concentration estimation techniques is expected to drive the market with potential avenues.

Besides, various candidate biomarkers developed through proteomics and genomics research can serve as predictive indexes for producing safer and more effective drugs. In the discovery stage, differential proteomic analysis with the help of mass spectrometry enables the recognition of candidates linked with a specific mechanism relevant to disease progression and affected by drug treatment.

Although technological advancements continue to take place for simplification protein estimation, the high cost of technology and assays are anticipated to restrict the usage of these assays and technologies under certain circumstances. For instance, Mass Spectroscopy (MS), which is often used for functional proteomics, is considered expensive and slow by researchers. In targeted MS, custom antibodies are required for each target to perform immunoaffinity enrichment of peptides. This process is observed to be expensive as well as lengthy.

The increasing need to comprehend various chronic diseases at a molecular level and then develop therapeutic solutions is estimated to support these organizations in investing in research and development programs. Besides, Public Health Genomics at the National Cancer Institute (NCI) boosts the incorporation of genomics and personalized medicine into the research of public health cancer to diminish the burden of cancer all over the world.

COVID-19 Impact Analysis

The COVID-19 outbreak has negatively affected the growth of the market. The centers are closed, and the laboratories are busy with the COVID-19 test, which will hamper the forecast period's market growth.

Industry Analysis

The global protein detection quantification market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis etc.

Segment Analysis

The colorimetric assays segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The colorimetric assays segment held the largest market share due to its convenience rate and wide availability of the reagents for its implementation. Colorimetric assays are based on the binding of a specific dye to the rhamnolipid.

Colorimetric assays help distinguish a particular enzyme from another, quantitate catalytic activity, and inhibit this activity, generate proliferative and toxicity profiles, and even determine the concentration of proteins in solution. They are a simple and convenient way to visualize biological processes.

In colorimetric assays, the substrate is converted by the enzyme into a soluble, colored reaction product. This allows precise determination of the enzyme activity by optical density, such as peroxidase activity is measured by reducing the substrate in the presence of hydrogen peroxide, producing a soluble chromogen that is measured with a spectrophotometer. These colorimetric assay methods are often used for microtiter plate-based ELISAs in combination with an automated spectrophotometer.

The testing of protein concentration was done using citrate buffer with tetra bromophenol blue, and the change of color observed was from yellow to blue. These are well-known colorimetric assays commonly used in urine analysis. The different chemicals and enzymes were spotted at the last step of the device fabrication and left to dry in the detection zones. Similar glucose and protein tests were tried on devices patterned with different methods.

Kinases and phosphatases mediate various cellular processes like metabolism, gene transcription and translation, protein-protein interactions, and apoptosis through protein phosphorylation and dephosphorylation. For this reason, many different technologies, including various colorimetric assays, exist to detect these enzymes and their activity. This factor will drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share of the global protein detection quantification market

North America dominated the global protein detection quantification market and is expected to grow at the highest CAGR during the forecast period. The region is estimated to be driven by the US mainly due to leading market players in the country and a well-established healthcare framework in the US. A combination of factors such as developed infrastructure, an increase in R&D investment, and growing cases of various diseases in the region are the factors attributed to the market growth in the U.S.

Competitive Landscape

The global protein detection quantification market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify Merck & Co., Inc., Danaher, RayBiotech, Inc., Innovate, Shimadzu Corporation, and PerkinElmer Inc, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and GE Healthcare are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for protein detection quantification worldwide. For instance, In August 2020, Oil-Dri Corporation of America, the leading manufacturer of sorbent minerals, parent company to Amlan International, announces that the European Patent Office has issued Patent EP 2906238. The patent covers the unique formulation of two existing mineral-based natural feed additives, Varium for poultry and NeoPrime for swine, that help global animal protein producers thrive in an era of antibiotic-free production.

Key Companies to Watch

Bio-Rad Laboratories

Overview: Bio-Rad Laboratories, Inc. is an American company that continued to produce innovative and useful products in the healthcare industry that assist life science researchers in accelerating the discovery process, and medical diagnostic labs obtain faster better results.

Product Portfolio: DC Protein Assay Reagents Package- Reagent pack for colorimetric assays, includes 250 ml alkaline copper tartrate, 2 L dilute Folin reagent, 5 ml surfactant solution; 450 assays.

The global protein detection quantification market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Technology
  • 3.2. Market Snippet by Product
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End-User
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Increasing need to comprehend various chronic diseases at a molecular level
    • 4.2.2. Rising demand for protein quantification in laboratories
  • 4.3. Restraints
    • 4.3.1. The high cost of assays and technology are expected to limit the utilization.
  • 4.4. Impact Analysis
  • 4.5. Opportunity

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Analysis
  • 5.6. Post Sales Services Analysis

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Colorimetric Assays *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2020-2028
  • 6.3. Immunological methods
  • 6.4. Chromatography
  • 6.5. Mass Spectrometry
  • 6.6. Spectroscopy Instruments
  • 6.7. Others

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Kits & Reagents/Consumables
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Instruments
  • 7.4. Services

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Drug discovery and development
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Clinical Diagnosis
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Academic Research Institutes
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Biotechnology and Pharmaceutical Companies
  • 9.4. Contract Research Organization
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merck & Co., Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Developments
    • 12.1.4. Financial Overview
  • 12.2. Danaher
  • 12.3. RayBiotech, Inc.
  • 12.4. Inanovate, Inc.
  • 12.5. Shimadzu Corporation
  • 12.6. PerkinElmer Inc
  • 12.7. Bio-Rad Laboratories, Inc.
  • 12.8. Thermo Fisher Scientific
  • 12.9. GE Healthcare
  • 12.10. Hartalega Holdings Bhd (*List is not exhaustive)

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us